Home / Inspections / 1308772

FDA Inspection 1308772 — Institute for Reproductive Medicine and Science at Saint Barnabas, P.A.

Institute for Reproductive Medicine and Science at Saint Barnabas, P.A. — FEI 3001047110

The FDA completed an inspection of Institute for Reproductive Medicine and Science at Saint Barnabas, P.A. on March 13, 2026 in Livingston, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 13, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Livingston, NJ (United States)

Facility

Other inspections at this facility

  • 1219451 (NAI Wed Sep 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1115356 (NAI Wed Jan 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1059965 (NAI Thu Jul 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 974406 (NAI Fri May 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 861410 (NAI Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources